Marine Derived Drugs Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Marine Derived Drugs market size was valued at USD 2410.8 million in 2022 and is forecast to a readjusted size of USD 4246 million by 2029 with a CAGR of 8.4% during review period.

Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.

The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.

Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%. North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent. In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.

This report is a detailed and comprehensive analysis for global Marine Derived Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Marine Derived Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Marine Derived Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Marine Derived Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Marine Derived Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Marine Derived Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Marine Derived Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Seattle Genetics
   Eisai Co
   Tekada
   Pfizer
   Pharma Mar
   Johnson and Johnson
   GSK
   TerSera Therapeutics
   Teva

   Mollusk
   Sponge
   Tunicate
   Fish
   Others

   Antitumor Drugs
   Anti-Cardiovascular Drugs
   Others

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Marine Derived Drugs Market in 2025?

The marine-derived drugs market has strong potential due to the vast untapped marine biodiversity, offering unique bioactive compounds. Advances in biotechnology and genomics enable more efficient extraction and identification of these compounds. Additionally, increasing demand for natural and sustainable treatments further drives the market.

What weaknesses could affect the Marine Derived Drugs Market in 2025?

One key weakness is the high cost of research and development in marine drug discovery, which can limit investment in the sector. There are also challenges related to the sustainability and scalability of sourcing marine organisms, and concerns over environmental impact and regulatory hurdles.

What opportunities exist in the Marine Derived Drugs Market in 2025?

The growing interest in personalized medicine and the need for novel treatments for diseases like cancer, inflammation, and neurological disorders presents a significant opportunity. Collaborative research between pharmaceutical companies and marine biologists could unlock new therapeutic applications, while advancements in sustainable harvesting techniques may improve market growth.

What threats could impact the Marine Derived Drugs Market in 2025?

Increasing competition from synthetic drugs and other natural sources of pharmaceuticals poses a threat to the marine-derived drugs market. Environmental changes and over-exploitation of marine resources could lead to a decrease in available species, further complicating sourcing and sustainable development of marine drugs.

What political factors influence the Marine Derived Drugs Market in 2025?

Government regulations regarding the sustainable extraction of marine organisms and environmental protections play a critical role in shaping the marine drugs market. Additionally, international policies on biodiversity and conservation efforts can impact the availability of marine resources for pharmaceutical use.

How do economic factors affect the Marine Derived Drugs Market in 2025?

The high cost of R&D and limited commercial availability of marine-derived drugs may make them less accessible, particularly in emerging markets. However, as demand for natural, sustainable treatments increases, the market could experience growth, especially with rising investments in biotechnology.

What social factors impact the Marine Derived Drugs Market in 2025?

The growing consumer preference for natural and eco-friendly products is driving demand for marine-derived drugs. Public awareness about the benefits of marine resources in healthcare is also growing, leading to an increased willingness to adopt these treatments for chronic diseases, particularly in developed markets.

What technological factors are relevant to the Marine Derived Drugs Market in 2025?

Advancements in biotechnology, genomics, and marine exploration technologies are enabling more efficient extraction and identification of bioactive compounds. New innovations in sustainable harvesting techniques and drug development platforms are likely to enhance the market's growth and accessibility.

What environmental factors affect the Marine Derived Drugs Market in 2025?

Environmental concerns regarding over-fishing, habitat destruction, and climate change can threaten the sustainability of marine resources. Strict environmental regulations are pushing for more sustainable practices in sourcing marine organisms for drug development.

What legal factors impact the Marine Derived Drugs Market in 2025?

Intellectual property rights and patent laws around marine-derived drugs are critical in determining market competition. Legal challenges related to the sustainable and ethical sourcing of marine organisms may also arise, with increased scrutiny on environmental impact and conservation efforts.

Who are the suppliers in the Marine Derived Drugs Market in 2025?

Suppliers include marine biologists, pharmaceutical companies, biotechnology firms, and organizations focused on sustainable marine resource harvesting. They provide raw materials, research findings, and innovative technologies necessary for developing marine-derived drugs.

What inputs are required for the Marine Derived Drugs Market in 2025?

Inputs include marine organisms (such as algae, corals, and marine microorganisms), advanced extraction technologies, biotechnology tools, research data, and regulatory compliance for sustainability and safety.

What processes are involved in the Marine Derived Drugs Market in 2025?

Key processes involve marine resource collection, bioactive compound identification, clinical research and trials, drug development, regulatory approval, and manufacturing of final pharmaceutical products. Sustainable sourcing practices and ethical considerations also play an important role.

Who are the customers in the Marine Derived Drugs Market in 2025?

Customers include pharmaceutical companies, healthcare providers, biotechnology firms, researchers, and ultimately patients seeking new and innovative treatments for various diseases, especially chronic conditions and cancers.

What are the outputs of the Marine Derived Drugs Market in 2025?

Outputs are the final marine-derived drugs, including pharmaceutical products, treatments, and therapeutics. These can address a range of medical conditions, including cancer, inflammation, and neurodegenerative diseases, contributing to the overall growth of the healthcare industry.

How strong is the threat of new entrants in the Marine Derived Drugs Market in 2025?

The threat of new entrants is moderate. While the potential for growth in marine-derived drugs is attractive, the high cost of R&D, strict regulatory requirements, and the need for specialized knowledge in marine biology and biotechnology create barriers to entry for new players.

How intense is the rivalry among existing competitors in the Marine Derived Drugs Market in 2025?

The rivalry is moderate to high. As the market for natural, sustainable treatments grows, companies are competing to discover novel marine bioactive compounds and secure patents. However, the specialized nature of the industry limits the number of key players, reducing the intensity of competition.

What is the bargaining power of suppliers in the Marine Derived Drugs Market in 2025?

The bargaining power of suppliers is high. Suppliers of marine organisms and specialized biotechnology tools control essential resources for drug development. Additionally, the limited availability of certain marine species and the high cost of extraction techniques further increase their power.

What is the bargaining power of buyers in the Marine Derived Drugs Market in 2025?

The bargaining power of buyers is relatively low. While there are other pharmaceutical alternatives, the uniqueness and efficacy of marine-derived drugs, particularly in treating complex diseases, reduce buyers' ability to influence prices significantly, especially in markets with limited treatment options.

How strong is the threat of substitutes in the Marine Derived Drugs Market in 2025?

The threat of substitutes is moderate. While synthetic drugs and other natural sources of pharmaceuticals offer alternatives, marine-derived drugs provide distinct therapeutic benefits that are difficult to replicate, especially for certain diseases like cancer and neurological disorders.

What are the key suppliers in the upstream of the Marine Derived Drugs Market in 2025?

Key suppliers include marine research institutions, biotechnology companies, marine biologists, and companies specializing in sustainable marine resource harvesting. These suppliers provide raw marine organisms, research findings, and innovative extraction technologies necessary for drug discovery.

What are the primary inputs required in the upstream of the Marine Derived Drugs Market in 2025?

The primary inputs include marine organisms (algae, corals, marine microorganisms), advanced biotechnological tools for compound extraction, laboratory equipment, and research data. These inputs are essential for identifying and isolating bioactive compounds with therapeutic potential.

What processes are involved in the upstream of the Marine Derived Drugs Market in 2025?

Upstream processes involve marine exploration, collection of marine organisms, extraction of bioactive compounds, and initial research into the compounds' therapeutic effects. This stage also includes the development of sustainable harvesting practices and ensuring environmental and regulatory compliance.

What challenges exist in the upstream of the Marine Derived Drugs Market in 2025?

Challenges include the high cost of marine exploration, the sustainability of harvesting practices, and the potential over-exploitation of marine resources. Additionally, there are concerns regarding the complexity of extracting bioactive compounds and the long timelines required for research and development.

What opportunities exist in the upstream of the Marine Derived Drugs Market in 2025?

Opportunities include advancements in marine biotechnology and genomics that could improve the efficiency of extracting and identifying valuable compounds. There is also potential for collaboration between pharmaceutical companies and marine research institutions to discover new therapeutic applications from marine organisms.

What are the key players in the midstream of the Marine Derived Drugs Market in 2025?

Key players in the midstream include pharmaceutical companies, biotechnology firms, and contract research organizations (CROs). These entities focus on refining and processing marine-derived bioactive compounds into pharmaceutical formulations, conducting clinical trials, and securing regulatory approvals.

What are the main activities in the midstream of the Marine Derived Drugs Market in 2025?

Midstream activities involve the synthesis and processing of bioactive compounds derived from marine organisms, formulation development, preclinical and clinical testing, and the regulatory approval process. These steps are critical to turning raw marine resources into viable therapeutic products.

What challenges exist in the midstream of the Marine Derived Drugs Market in 2025?

Challenges in the midstream include the complexity and high cost of clinical trials, long development timelines, and ensuring the scalability of marine-derived compounds. Furthermore, navigating the regulatory landscape and obtaining market approval for novel marine-based drugs can be difficult and time-consuming.

What opportunities exist in the midstream of the Marine Derived Drugs Market in 2025?

Opportunities include the growing demand for natural and sustainable treatments, especially in oncology and neurological disorders. Advancements in clinical research methodologies, biotechnology, and collaboration with research institutions can shorten development timelines and improve the success rates of marine-derived drugs.

How is innovation impacting the midstream of the Marine Derived Drugs Market in 2025?

Innovation in drug formulation technologies, clinical trial design, and regulatory strategies is significantly improving the efficiency and success of developing marine-derived drugs. Enhanced technologies for extracting and synthesizing bioactive compounds also facilitate the discovery of new therapeutic agents with broader applications.

What are the key players in the downstream of the Marine Derived Drugs Market in 2025?

Key players in the downstream include pharmaceutical distributors, healthcare providers, hospitals, and pharmacies. These entities are responsible for the commercialization, distribution, and administration of marine-derived drugs to end consumers, including patients and healthcare professionals.

What are the main activities in the downstream of the Marine Derived Drugs Market in 2025?

Downstream activities focus on the marketing, sales, distribution, and post-market monitoring of marine-derived drugs. This stage includes physician education, patient access programs, and ensuring the drugs are available in both local and global markets through various healthcare channels.

What challenges exist in the downstream of the Marine Derived Drugs Market in 2025?

Challenges include the high cost of marine-derived drugs, which could limit accessibility in price-sensitive markets. Additionally, there are barriers related to awareness and understanding of these novel therapies among healthcare providers and patients, which could slow adoption rates.

What opportunities exist in the downstream of the Marine Derived Drugs Market in 2025?

Opportunities lie in increasing awareness and demand for natural and sustainable treatments, particularly in the treatment of chronic and complex diseases. Expanding global healthcare access and focusing on personalized medicine can also drive the growth of marine-derived drugs in various therapeutic areas.

How is innovation impacting the downstream of the Marine Derived Drugs Market in 2025?

Innovation in distribution networks, digital health platforms, and patient engagement strategies is improving access to marine-derived drugs. Advancements in telemedicine and remote patient monitoring are also facilitating the wider use of these treatments, especially in underserved regions and niche therapeutic markets.

Chapter 1, to describe Marine Derived Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Marine Derived Drugs, with price, sales, revenue and global market share of Marine Derived Drugs from 2018 to 2023.
Chapter 3, the Marine Derived Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Marine Derived Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Marine Derived Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Marine Derived Drugs.
Chapter 14 and 15, to describe Marine Derived Drugs sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Marine Derived Drugs
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Marine Derived Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Mollusk
       1.3.3 Sponge
       1.3.4 Tunicate
       1.3.5 Fish
       1.3.6 Others
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Marine Derived Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Antitumor Drugs
       1.4.3 Anti-Cardiovascular Drugs
       1.4.4 Others
   1.5 Global Marine Derived Drugs Market Size & Forecast
       1.5.1 Global Marine Derived Drugs Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Marine Derived Drugs Sales Quantity (2018-2029)
       1.5.3 Global Marine Derived Drugs Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Seattle Genetics
       2.1.1 Seattle Genetics Details
       2.1.2 Seattle Genetics Major Business
       2.1.3 Seattle Genetics Marine Derived Drugs Product and Services
       2.1.4 Seattle Genetics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Seattle Genetics Recent Developments/Updates
   2.2 Eisai Co
       2.2.1 Eisai Co Details
       2.2.2 Eisai Co Major Business
       2.2.3 Eisai Co Marine Derived Drugs Product and Services
       2.2.4 Eisai Co Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Eisai Co Recent Developments/Updates
   2.3 Tekada
       2.3.1 Tekada Details
       2.3.2 Tekada Major Business
       2.3.3 Tekada Marine Derived Drugs Product and Services
       2.3.4 Tekada Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Tekada Recent Developments/Updates
   2.4 Pfizer
       2.4.1 Pfizer Details
       2.4.2 Pfizer Major Business
       2.4.3 Pfizer Marine Derived Drugs Product and Services
       2.4.4 Pfizer Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Pfizer Recent Developments/Updates
   2.5 Pharma Mar
       2.5.1 Pharma Mar Details
       2.5.2 Pharma Mar Major Business
       2.5.3 Pharma Mar Marine Derived Drugs Product and Services
       2.5.4 Pharma Mar Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Pharma Mar Recent Developments/Updates
   2.6 Johnson and Johnson
       2.6.1 Johnson and Johnson Details
       2.6.2 Johnson and Johnson Major Business
       2.6.3 Johnson and Johnson Marine Derived Drugs Product and Services
       2.6.4 Johnson and Johnson Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Johnson and Johnson Recent Developments/Updates
   2.7 GSK
       2.7.1 GSK Details
       2.7.2 GSK Major Business
       2.7.3 GSK Marine Derived Drugs Product and Services
       2.7.4 GSK Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 GSK Recent Developments/Updates
   2.8 TerSera Therapeutics
       2.8.1 TerSera Therapeutics Details
       2.8.2 TerSera Therapeutics Major Business
       2.8.3 TerSera Therapeutics Marine Derived Drugs Product and Services
       2.8.4 TerSera Therapeutics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 TerSera Therapeutics Recent Developments/Updates
   2.9 Teva
       2.9.1 Teva Details
       2.9.2 Teva Major Business
       2.9.3 Teva Marine Derived Drugs Product and Services
       2.9.4 Teva Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Teva Recent Developments/Updates

3 Competitive Environment: Marine Derived Drugs by Manufacturer

   3.1 Global Marine Derived Drugs Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Marine Derived Drugs Revenue by Manufacturer (2018-2023)
   3.3 Global Marine Derived Drugs Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Marine Derived Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Marine Derived Drugs Manufacturer Market Share in 2022
       3.4.2 Top 6 Marine Derived Drugs Manufacturer Market Share in 2022
   3.5 Marine Derived Drugs Market: Overall Company Footprint Analysis
       3.5.1 Marine Derived Drugs Market: Region Footprint
       3.5.2 Marine Derived Drugs Market: Company Product Type Footprint
       3.5.3 Marine Derived Drugs Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Marine Derived Drugs Market Size by Region
       4.1.1 Global Marine Derived Drugs Sales Quantity by Region (2018-2029)
       4.1.2 Global Marine Derived Drugs Consumption Value by Region (2018-2029)
       4.1.3 Global Marine Derived Drugs Average Price by Region (2018-2029)
   4.2 North America Marine Derived Drugs Consumption Value (2018-2029)
   4.3 Europe Marine Derived Drugs Consumption Value (2018-2029)
   4.4 Asia-Pacific Marine Derived Drugs Consumption Value (2018-2029)
   4.5 South America Marine Derived Drugs Consumption Value (2018-2029)
   4.6 Middle East and Africa Marine Derived Drugs Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Marine Derived Drugs Sales Quantity by Type (2018-2029)
   5.2 Global Marine Derived Drugs Consumption Value by Type (2018-2029)
   5.3 Global Marine Derived Drugs Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Marine Derived Drugs Sales Quantity by Application (2018-2029)
   6.2 Global Marine Derived Drugs Consumption Value by Application (2018-2029)
   6.3 Global Marine Derived Drugs Average Price by Application (2018-2029)

7 North America

   7.1 North America Marine Derived Drugs Sales Quantity by Type (2018-2029)
   7.2 North America Marine Derived Drugs Sales Quantity by Application (2018-2029)
   7.3 North America Marine Derived Drugs Market Size by Country
       7.3.1 North America Marine Derived Drugs Sales Quantity by Country (2018-2029)
       7.3.2 North America Marine Derived Drugs Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Marine Derived Drugs Sales Quantity by Type (2018-2029)
   8.2 Europe Marine Derived Drugs Sales Quantity by Application (2018-2029)
   8.3 Europe Marine Derived Drugs Market Size by Country
       8.3.1 Europe Marine Derived Drugs Sales Quantity by Country (2018-2029)
       8.3.2 Europe Marine Derived Drugs Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Marine Derived Drugs Market Size by Region
       9.3.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Marine Derived Drugs Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Marine Derived Drugs Sales Quantity by Type (2018-2029)
   10.2 South America Marine Derived Drugs Sales Quantity by Application (2018-2029)
   10.3 South America Marine Derived Drugs Market Size by Country
       10.3.1 South America Marine Derived Drugs Sales Quantity by Country (2018-2029)
       10.3.2 South America Marine Derived Drugs Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Marine Derived Drugs Market Size by Country
       11.3.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Marine Derived Drugs Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Marine Derived Drugs Market Drivers
   12.2 Marine Derived Drugs Market Restraints
   12.3 Marine Derived Drugs Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Marine Derived Drugs and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Marine Derived Drugs
   13.3 Marine Derived Drugs Production Process
   13.4 Marine Derived Drugs Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Marine Derived Drugs Typical Distributors
   14.3 Marine Derived Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Marine Derived Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Marine Derived Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Seattle Genetics Basic Information, Manufacturing Base and Competitors
   Table 4. Seattle Genetics Major Business
   Table 5. Seattle Genetics Marine Derived Drugs Product and Services
   Table 6. Seattle Genetics Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Seattle Genetics Recent Developments/Updates
   Table 8. Eisai Co Basic Information, Manufacturing Base and Competitors
   Table 9. Eisai Co Major Business
   Table 10. Eisai Co Marine Derived Drugs Product and Services
   Table 11. Eisai Co Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Eisai Co Recent Developments/Updates
   Table 13. Tekada Basic Information, Manufacturing Base and Competitors
   Table 14. Tekada Major Business
   Table 15. Tekada Marine Derived Drugs Product and Services
   Table 16. Tekada Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Tekada Recent Developments/Updates
   Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
   Table 19. Pfizer Major Business
   Table 20. Pfizer Marine Derived Drugs Product and Services
   Table 21. Pfizer Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Pfizer Recent Developments/Updates
   Table 23. Pharma Mar Basic Information, Manufacturing Base and Competitors
   Table 24. Pharma Mar Major Business
   Table 25. Pharma Mar Marine Derived Drugs Product and Services
   Table 26. Pharma Mar Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Pharma Mar Recent Developments/Updates
   Table 28. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
   Table 29. Johnson and Johnson Major Business
   Table 30. Johnson and Johnson Marine Derived Drugs Product and Services
   Table 31. Johnson and Johnson Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Johnson and Johnson Recent Developments/Updates
   Table 33. GSK Basic Information, Manufacturing Base and Competitors
   Table 34. GSK Major Business
   Table 35. GSK Marine Derived Drugs Product and Services
   Table 36. GSK Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. GSK Recent Developments/Updates
   Table 38. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
   Table 39. TerSera Therapeutics Major Business
   Table 40. TerSera Therapeutics Marine Derived Drugs Product and Services
   Table 41. TerSera Therapeutics Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. TerSera Therapeutics Recent Developments/Updates
   Table 43. Teva Basic Information, Manufacturing Base and Competitors
   Table 44. Teva Major Business
   Table 45. Teva Marine Derived Drugs Product and Services
   Table 46. Teva Marine Derived Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Teva Recent Developments/Updates
   Table 48. Global Marine Derived Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 49. Global Marine Derived Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 50. Global Marine Derived Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 51. Market Position of Manufacturers in Marine Derived Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 52. Head Office and Marine Derived Drugs Production Site of Key Manufacturer
   Table 53. Marine Derived Drugs Market: Company Product Type Footprint
   Table 54. Marine Derived Drugs Market: Company Product Application Footprint
   Table 55. Marine Derived Drugs New Market Entrants and Barriers to Market Entry
   Table 56. Marine Derived Drugs Mergers, Acquisition, Agreements, and Collaborations
   Table 57. Global Marine Derived Drugs Sales Quantity by Region (2018-2023) & (K Units)
   Table 58. Global Marine Derived Drugs Sales Quantity by Region (2024-2029) & (K Units)
   Table 59. Global Marine Derived Drugs Consumption Value by Region (2018-2023) & (USD Million)
   Table 60. Global Marine Derived Drugs Consumption Value by Region (2024-2029) & (USD Million)
   Table 61. Global Marine Derived Drugs Average Price by Region (2018-2023) & (USD/Unit)
   Table 62. Global Marine Derived Drugs Average Price by Region (2024-2029) & (USD/Unit)
   Table 63. Global Marine Derived Drugs Sales Quantity by Type (2018-2023) & (K Units)
   Table 64. Global Marine Derived Drugs Sales Quantity by Type (2024-2029) & (K Units)
   Table 65. Global Marine Derived Drugs Consumption Value by Type (2018-2023) & (USD Million)
   Table 66. Global Marine Derived Drugs Consumption Value by Type (2024-2029) & (USD Million)
   Table 67. Global Marine Derived Drugs Average Price by Type (2018-2023) & (USD/Unit)
   Table 68. Global Marine Derived Drugs Average Price by Type (2024-2029) & (USD/Unit)
   Table 69. Global Marine Derived Drugs Sales Quantity by Application (2018-2023) & (K Units)
   Table 70. Global Marine Derived Drugs Sales Quantity by Application (2024-2029) & (K Units)
   Table 71. Global Marine Derived Drugs Consumption Value by Application (2018-2023) & (USD Million)
   Table 72. Global Marine Derived Drugs Consumption Value by Application (2024-2029) & (USD Million)
   Table 73. Global Marine Derived Drugs Average Price by Application (2018-2023) & (USD/Unit)
   Table 74. Global Marine Derived Drugs Average Price by Application (2024-2029) & (USD/Unit)
   Table 75. North America Marine Derived Drugs Sales Quantity by Type (2018-2023) & (K Units)
   Table 76. North America Marine Derived Drugs Sales Quantity by Type (2024-2029) & (K Units)
   Table 77. North America Marine Derived Drugs Sales Quantity by Application (2018-2023) & (K Units)
   Table 78. North America Marine Derived Drugs Sales Quantity by Application (2024-2029) & (K Units)
   Table 79. North America Marine Derived Drugs Sales Quantity by Country (2018-2023) & (K Units)
   Table 80. North America Marine Derived Drugs Sales Quantity by Country (2024-2029) & (K Units)
   Table 81. North America Marine Derived Drugs Consumption Value by Country (2018-2023) & (USD Million)
   Table 82. North America Marine Derived Drugs Consumption Value by Country (2024-2029) & (USD Million)
   Table 83. Europe Marine Derived Drugs Sales Quantity by Type (2018-2023) & (K Units)
   Table 84. Europe Marine Derived Drugs Sales Quantity by Type (2024-2029) & (K Units)
   Table 85. Europe Marine Derived Drugs Sales Quantity by Application (2018-2023) & (K Units)
   Table 86. Europe Marine Derived Drugs Sales Quantity by Application (2024-2029) & (K Units)
   Table 87. Europe Marine Derived Drugs Sales Quantity by Country (2018-2023) & (K Units)
   Table 88. Europe Marine Derived Drugs Sales Quantity by Country (2024-2029) & (K Units)
   Table 89. Europe Marine Derived Drugs Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Marine Derived Drugs Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Marine Derived Drugs Sales Quantity by Type (2018-2023) & (K Units)
   Table 92. Asia-Pacific Marine Derived Drugs Sales Quantity by Type (2024-2029) & (K Units)
   Table 93. Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2018-2023) & (K Units)
   Table 94. Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2024-2029) & (K Units)
   Table 95. Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2018-2023) & (K Units)
   Table 96. Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2024-2029) & (K Units)
   Table 97. Asia-Pacific Marine Derived Drugs Consumption Value by Region (2018-2023) & (USD Million)
   Table 98. Asia-Pacific Marine Derived Drugs Consumption Value by Region (2024-2029) & (USD Million)
   Table 99. South America Marine Derived Drugs Sales Quantity by Type (2018-2023) & (K Units)
   Table 100. South America Marine Derived Drugs Sales Quantity by Type (2024-2029) & (K Units)
   Table 101. South America Marine Derived Drugs Sales Quantity by Application (2018-2023) & (K Units)
   Table 102. South America Marine Derived Drugs Sales Quantity by Application (2024-2029) & (K Units)
   Table 103. South America Marine Derived Drugs Sales Quantity by Country (2018-2023) & (K Units)
   Table 104. South America Marine Derived Drugs Sales Quantity by Country (2024-2029) & (K Units)
   Table 105. South America Marine Derived Drugs Consumption Value by Country (2018-2023) & (USD Million)
   Table 106. South America Marine Derived Drugs Consumption Value by Country (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Marine Derived Drugs Sales Quantity by Type (2018-2023) & (K Units)
   Table 108. Middle East & Africa Marine Derived Drugs Sales Quantity by Type (2024-2029) & (K Units)
   Table 109. Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2018-2023) & (K Units)
   Table 110. Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2024-2029) & (K Units)
   Table 111. Middle East & Africa Marine Derived Drugs Sales Quantity by Region (2018-2023) & (K Units)
   Table 112. Middle East & Africa Marine Derived Drugs Sales Quantity by Region (2024-2029) & (K Units)
   Table 113. Middle East & Africa Marine Derived Drugs Consumption Value by Region (2018-2023) & (USD Million)
   Table 114. Middle East & Africa Marine Derived Drugs Consumption Value by Region (2024-2029) & (USD Million)
   Table 115. Marine Derived Drugs Raw Material
   Table 116. Key Manufacturers of Marine Derived Drugs Raw Materials
   Table 117. Marine Derived Drugs Typical Distributors
   Table 118. Marine Derived Drugs Typical Customers

List of Figures

   Figure 1. Marine Derived Drugs Picture
   Figure 2. Global Marine Derived Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Marine Derived Drugs Consumption Value Market Share by Type in 2022
   Figure 4. Mollusk Examples
   Figure 5. Sponge Examples
   Figure 6. Tunicate Examples
   Figure 7. Fish Examples
   Figure 8. Others Examples
   Figure 9. Global Marine Derived Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 10. Global Marine Derived Drugs Consumption Value Market Share by Application in 2022
   Figure 11. Antitumor Drugs Examples
   Figure 12. Anti-Cardiovascular Drugs Examples
   Figure 13. Others Examples
   Figure 14. Global Marine Derived Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 15. Global Marine Derived Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 16. Global Marine Derived Drugs Sales Quantity (2018-2029) & (K Units)
   Figure 17. Global Marine Derived Drugs Average Price (2018-2029) & (USD/Unit)
   Figure 18. Global Marine Derived Drugs Sales Quantity Market Share by Manufacturer in 2022
   Figure 19. Global Marine Derived Drugs Consumption Value Market Share by Manufacturer in 2022
   Figure 20. Producer Shipments of Marine Derived Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 21. Top 3 Marine Derived Drugs Manufacturer (Consumption Value) Market Share in 2022
   Figure 22. Top 6 Marine Derived Drugs Manufacturer (Consumption Value) Market Share in 2022
   Figure 23. Global Marine Derived Drugs Sales Quantity Market Share by Region (2018-2029)
   Figure 24. Global Marine Derived Drugs Consumption Value Market Share by Region (2018-2029)
   Figure 25. North America Marine Derived Drugs Consumption Value (2018-2029) & (USD Million)
   Figure 26. Europe Marine Derived Drugs Consumption Value (2018-2029) & (USD Million)
   Figure 27. Asia-Pacific Marine Derived Drugs Consumption Value (2018-2029) & (USD Million)
   Figure 28. South America Marine Derived Drugs Consumption Value (2018-2029) & (USD Million)
   Figure 29. Middle East & Africa Marine Derived Drugs Consumption Value (2018-2029) & (USD Million)
   Figure 30. Global Marine Derived Drugs Sales Quantity Market Share by Type (2018-2029)
   Figure 31. Global Marine Derived Drugs Consumption Value Market Share by Type (2018-2029)
   Figure 32. Global Marine Derived Drugs Average Price by Type (2018-2029) & (USD/Unit)
   Figure 33. Global Marine Derived Drugs Sales Quantity Market Share by Application (2018-2029)
   Figure 34. Global Marine Derived Drugs Consumption Value Market Share by Application (2018-2029)
   Figure 35. Global Marine Derived Drugs Average Price by Application (2018-2029) & (USD/Unit)
   Figure 36. North America Marine Derived Drugs Sales Quantity Market Share by Type (2018-2029)
   Figure 37. North America Marine Derived Drugs Sales Quantity Market Share by Application (2018-2029)
   Figure 38. North America Marine Derived Drugs Sales Quantity Market Share by Country (2018-2029)
   Figure 39. North America Marine Derived Drugs Consumption Value Market Share by Country (2018-2029)
   Figure 40. United States Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Canada Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Mexico Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 43. Europe Marine Derived Drugs Sales Quantity Market Share by Type (2018-2029)
   Figure 44. Europe Marine Derived Drugs Sales Quantity Market Share by Application (2018-2029)
   Figure 45. Europe Marine Derived Drugs Sales Quantity Market Share by Country (2018-2029)
   Figure 46. Europe Marine Derived Drugs Consumption Value Market Share by Country (2018-2029)
   Figure 47. Germany Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. France Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. United Kingdom Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Russia Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Italy Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 52. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Type (2018-2029)
   Figure 53. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Application (2018-2029)
   Figure 54. Asia-Pacific Marine Derived Drugs Sales Quantity Market Share by Region (2018-2029)
   Figure 55. Asia-Pacific Marine Derived Drugs Consumption Value Market Share by Region (2018-2029)
   Figure 56. China Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Japan Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Korea Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. India Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. Southeast Asia Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. Australia Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 62. South America Marine Derived Drugs Sales Quantity Market Share by Type (2018-2029)
   Figure 63. South America Marine Derived Drugs Sales Quantity Market Share by Application (2018-2029)
   Figure 64. South America Marine Derived Drugs Sales Quantity Market Share by Country (2018-2029)
   Figure 65. South America Marine Derived Drugs Consumption Value Market Share by Country (2018-2029)
   Figure 66. Brazil Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 67. Argentina Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 68. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Type (2018-2029)
   Figure 69. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Application (2018-2029)
   Figure 70. Middle East & Africa Marine Derived Drugs Sales Quantity Market Share by Region (2018-2029)
   Figure 71. Middle East & Africa Marine Derived Drugs Consumption Value Market Share by Region (2018-2029)
   Figure 72. Turkey Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Egypt Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. Saudi Arabia Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. South Africa Marine Derived Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 76. Marine Derived Drugs Market Drivers
   Figure 77. Marine Derived Drugs Market Restraints
   Figure 78. Marine Derived Drugs Market Trends
   Figure 79. Porters Five Forces Analysis
   Figure 80. Manufacturing Cost Structure Analysis of Marine Derived Drugs in 2022
   Figure 81. Manufacturing Process Analysis of Marine Derived Drugs
   Figure 82. Marine Derived Drugs Industrial Chain
   Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 84. Direct Channel Pros & Cons
   Figure 85. Indirect Channel Pros & Cons
   Figure 86. Methodology
   Figure 87. Research Process and Data Source